Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma (Phase 1)
Bile Duct Neoplasms (Phase 1)
Biliary Tract Neoplasms (Phase 1)
Breast Neoplasms (Phase 1)
Carcinoma, Ductal (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Small Cell (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Colorectal Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 1)
Genes, erbB-2 (Phase 1)
Head and Neck Neoplasms (Phase 1)
Inflammatory Breast Neoplasms (Phase 1)
Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 1)
Small Cell Lung Carcinoma (Phase 1)
Stomach Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue